Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey R Unger

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Journal of Family Practice|November 8, 2015
Med students: Look up from your EMRsJeffrey R Unger
The Journal of Family Practice|February 12, 2017
Staring down the opioid epidemicJeffrey R Unger
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 1, 2011
Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medicationsJeffrey R Unger, Christopher G Parkin
Clinical Diabetes : a Publication of the American Diabetes Association|February 2, 2019
A Pilot Study to Assess Clinical Utility and User Experience of Professional Continuous Glucose Monitoring Among People With Type 2 DiabetesKurt Midyett, Jeffrey R Unger, Eugene E Wright, et al.
Headache|April 21, 2007
Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS)Frederick G Freitag, Gary Finlayson, Alan M Rapoport, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Journal of Family Practice|November 8, 2015
Med students: Look up from your EMRsJeffrey R Unger
The Journal of Family Practice|February 12, 2017
Staring down the opioid epidemicJeffrey R Unger
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 1, 2011
Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medicationsJeffrey R Unger, Christopher G Parkin
Clinical Diabetes : a Publication of the American Diabetes Association|February 2, 2019
A Pilot Study to Assess Clinical Utility and User Experience of Professional Continuous Glucose Monitoring Among People With Type 2 DiabetesKurt Midyett, Jeffrey R Unger, Eugene E Wright, et al.
Headache|April 21, 2007
Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS)Frederick G Freitag, Gary Finlayson, Alan M Rapoport, et al.
Pageof 1